# Endothelial Protection in Post COVID-19 Patients With Sulodexide

> **NCT05371925** · PHASE3 · COMPLETED · sponsor: **Centro Medico del Noroeste** · enrollment: 206 (actual)

## Conditions studied

- Post COVID-19
- Endothelial Dysfunction
- Thrombosis

## Interventions

- **DRUG:** Sulodexide

## Key facts

- **NCT ID:** NCT05371925
- **Lead sponsor:** Centro Medico del Noroeste
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-01
- **Primary completion:** 2024-02-07
- **Final completion:** 2024-04-19
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2024-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05371925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05371925, "Endothelial Protection in Post COVID-19 Patients With Sulodexide". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05371925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*